NEW YORK (GenomeWeb) – Alere said Tuesday in a Form 8-K filed with the US Securities and Exchange Commission that it received notice that it is not in compliance with the New York Stock Exchange's continued listing requirements, after the firm failed to file its annual report 10-K in a timely manner.

In a letter to Alere on Friday, the NYSE noted that it may "commence delisting proceedings at any time if it deems that the circumstances warrant" that action, Alere said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.